Thrombospondin type-I domain-containing 7A (THSD7A) was identified as the target antigen in about 10% of patients with PLA2R-negative MN in European and North American populations, but THSD7A-associated membranous nephropathy has a low prevalence in Chinese patients11. Here, THSD7A is linked to membranous glomerulonephritis.